AI assistant
Cigna Group — Director's Dealing 2021
Mar 3, 2021
29918_dirs_2021-03-02_b89babf4-d6d1-4ab7-bfe5-67f682e89d3a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cigna Corp (CI)
CIK: 0001739940
Period of Report: 2021-02-26
Reporting Person: Manders Matthew G (Pres, Government and Solutions)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-02-26 | Common Stock, $.01 Par Value | A | 5357.0000 | $0.0000 | Acquired | 50998.0000 | Direct |
| 2021-02-26 | Common Stock, $.01 Par Value | F | 1072.0000 | $210.3100 | Disposed | 49926.0000 | Direct |
| 2021-02-26 | Common Stock, $.01 Par Value | F | 2270.0000 | $210.3100 | Disposed | 47656.0000 | Direct |
| 2021-03-01 | Common Stock, $.01 Par Value | S | 3087.0000 | $212.3700 | Disposed | 44569.0000 | Direct |
Footnotes
F1: The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2018-2020 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals.
F2: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares.
F3: Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares.
F4: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2020.